EUVIMEDEUVIMED entdecken
Open Access

Clinical Characteristics and Chemosensitivity in Germline TP53 Pathogenic Variant Cases Identified by Cancer Genomic Testing

Yosuke Saito, Yuki Hoshi, Masamichi Sato, Manabu Seino, Norikazu Watanabe, Masaaki Kawai, Shuhei Suzuki

Cancer Genomics - Proteomics · 2025

DOI: 10.21873/cgp.20506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2025. Verfasst von Yosuke Saito und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Yamagata City Hospital Saiseikan, Yamagata, Japan. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Germ-Line Mutation, Neoplasms, Li-Fraumeni Syndrome. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Germ-Line MutationNeoplasmsLi-Fraumeni SyndromeHumansMaleMiddle AgedFemaleAgedAdultAged, 80 and overRetrospective StudiesAdolescentChildYoung AdultChild, PreschoolInfantGenomicsGenetic Testing

Stichwörter der Autor:innen

Germline TP53Li-Fraumeni syndromecancer genome testchemotherapy

Substanzen

Tumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology, Yamagata City Hospital Saiseikan, Yamagata, Japan.
  • Department of Genetic Counseling, Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Department of Respiratory Medicine, Okitama General Hospital, Kawanishi, Japan.
  • Yamagata Hereditary Tumor Research Center, Yamagata University School of Medicine, Yamagata, Japan.
  • Department of Obstetrics and Gynecology, Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Department of Surgery I, Yamagata University Faculty of Medicine, Yamagata, Japan.

Zitieren

APA

Saito, Y., Hoshi, Y., Sato, M., Seino, M., Watanabe, N., Kawai, M., & Suzuki, S. (2025). Clinical Characteristics and Chemosensitivity in Germline TP53 Pathogenic Variant Cases Identified by Cancer Genomic Testing. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20506

Vancouver

Saito Y, Hoshi Y, Sato M, Seino M, Watanabe N, Kawai M, et al. Clinical Characteristics and Chemosensitivity in Germline TP53 Pathogenic Variant Cases Identified by Cancer Genomic Testing. Cancer Genomics - Proteomics. 2025. doi:10.21873/cgp.20506

BibTeX
@article{Saito2025,
  author = {Saito, Yosuke and Hoshi, Yuki and Sato, Masamichi and Seino, Manabu and Watanabe, Norikazu and Kawai, Masaaki and Suzuki, Shuhei},
  title = {Clinical Characteristics and Chemosensitivity in Germline TP53 Pathogenic Variant Cases Identified by Cancer Genomic Testing},
  journal = {Cancer Genomics - Proteomics},
  year = {2025},
  doi = {10.21873/cgp.20506}
}
Kostenlos starten →